drugset / Press release
Ultragenyx Announces Positive Data from Retrospective Study of UX007 Triheptanoin in Patients with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)
2013-09-16 · Ultragenyx Pharmaceutical Inc · original ultragenyx.com ↗
Ultragenyx Announces Positive Data from Retrospective Study of UX007 Triheptanoin in Patients with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)
The release as fetched from its publisher. ultragenyx.com ↗